Prognostic Enrichment is a clinical trial strategy of evaluating an intervention in a patient population with a higher rate of the unwanted event than the broader patient population (R. Temple (2010) <doi:10.1038/clpt.2010.233>). A higher event rate translates to a lower sample size for the clinical trial, which can have both practical and ethical advantages. This package is a tool to help evaluate biomarkers for prognostic enrichment of clinical trials.
| Version: |
0.2.0 |
| Imports: |
ggplot2, gridExtra, pROC, VGAM |
| Published: |
2016-07-04 |
| Author: |
Jeremy Roth [cre, aut],
Kathleen F. Kerr [aut],
Kehao Zhu [aut] |
| Maintainer: |
Jeremy Roth <jhroth at uw.edu> |
| BugReports: |
NA |
| License: |
GPL-2 | GPL-3 [expanded from: GPL (≥ 2)] |
| URL: |
NA |
| NeedsCompilation: |
no |
| CRAN checks: |
BioPET results |